基本信息
views: 8
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Francine Foss, professor of medicine in the Section of Medical Oncology at the Yale Cancer Center, is an internationally recognized clinician and clinical researcher with expertise in adult lymphomas and in stem cell allotransplantation. She has derived and tested therapies that have been used to treat thousands of cancer patients, and her research has potential to substantially impact the field of stem cell research, benefiting patients at Yale and around the world. Dr. Foss has brought a nationally established clinical trials program to the Yale Cancer Center. In her previous post at Tufts New England Medical Center in Boston, she designed, initiated and directed multi-center national clinical trials which led to FDA approval of several novel therapies for lymphomas. One of these, Interleukin-2 conjugated to Diphtheria toxin, was the first FDA-approved fusion biologic drug to be approved for use in the United States. She also developed a treatment for patients undergoing allogeneic stem cell transplant that reduced the development of graft-versus-host disease. These findings led to the initiation of two National Cancer Institute-sponsored trials to confirm these results in patients with lymphoma and myelodysplastic syndrome.
Research Interests
Papers共 351 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
EXPERT REVIEW OF ANTICANCER THERAPYno. 1-2 (2024): 41-58
Thomas Witzig,Lubomir Sokol,Won Seog Kim,Fatima de la Cruz Vicente, Alejandro Martin Garcia-Sancho,Ranjana Advani, Jose Maria Roncero Vidal,Raquel de Oña Navarrete,Ana Marín-Niebla,Antonia Rodriguez Izquierdo,Maria Jose Terol,Eva Domingo-Domenech,
Blood advances (2024)
Nature Communicationsno. 1 (2024): 1-16
The Journal of dermatological treatmentno. 1 (2024): 2360568-2360568
BLOODno. Supplement 1 (2023): 2132-2132
HemaSphere (2023): e1847498-e1847498
Transplantation and Cellular Therapyno. 2 (2023): S383-S384
Transplantation and Cellular Therapyno. 2 (2023): S392-S392
Load More
Author Statistics
#Papers: 360
#Citation: 10607
H-Index: 47
G-Index: 95
Sociability: 7
Diversity: 3
Activity: 56
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn